Cancer BiologybioRxivPreprint
Novel Synthetic Promoter Armed Oncolytic Herpes Simplex Virus For Treatment of PAX3-FOXO1 Positive Rhabdomyosarcoma
Cole W. Peters, Miriam Valenzuela-Cardenas, Conner K. Kidd…·Theodore Scott Nowicki
This paper develops a PAX3-FOXO1-targeted oncolytic herpes virus that improves tumor control in immunocompetent mouse models when combined with anti-PD1 therapy.
DOI 10.64898/2026.06.09.731216